NATRAJ PROTEINS LTD.

Natraj Proteins Ltd has announced a closure of its trading window from July 1, 2026, until 48 hours after the declaration of its Quarterly Un-audited Financial Results for the quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. All promoters, directors, KMPs, designated employees, and connected persons are advised not to trade in the company's shares during this period. The company is also in the process of intimating its designated depository, CDSL, at least two trading days prior to the commencement of the trading window closure.

Natraj Proteins Ltd has submitted audited financial results for the quarter/year ended March 31, 2026, along with the Statement of Assets and Liabilities, Cash Flow, and the Auditor's Report. The results were approved by the Audit Committee and Board of Directors on May 22, 2026. The Auditor's Report is self-explanatory with no modifications or qualifications. The company is in the process of filing the financial results in Integrated XBRL format and will host them on its website. The results will also be published in English and Hindi newspapers.

Natraj Proteins Ltd has submitted audited financial results for the year ended March 31, 2026, as approved by the Audit Committee and Board of Directors on May 22, 2026. The results, compliant with Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, include the Statement of Assets and Liabilities, Cash Flow, and Auditors' Report. The auditor's report is self-explanatory with no modifications or qualifications. The company is filing the results in Integrated XBRL format and will host them on its website, www.natrajproteins.com. The results will also be published in English and Hindi newspapers.

Natraj Proteins Ltd has scheduled a Board of Directors meeting on May 22, 2026, to consider and approve the audited financial results for the quarter/year ended March 31, 2026. The board will also review the audit report from the statutory auditors and the audited financial statements, including the balance sheet, profit and loss statement, cash flow statement, and changes in equity. The trading window is currently closed and will reopen 48 hours after the results are declared.

Natraj Proteins Ltd's Registrar and Share Transfer Agent, Ankit Consultancy Private Limited, has dispatched letters to holders of physical securities regarding mandatory furnishing of PAN, nomination choices, contact details, bank account details, and specimen signatures, as per SEBI circulars. Effective April 1, 2024, dividend/interest/redemption payments will be routed electronically only, advising shareholders to update KYC details. Shareholders can submit documents through in-person verification, hard copies, or electronically.

Natraj Proteins Ltd has announced that the trading window for shares will be closed from 1st April, 2026 till the completion of 48 hours after the declaration of audited financial results for the quarter and financial year ended on 31st March, 2026. This decision is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and BSE circulars. All Promoter and Promoter group, Directors, KMP’s, Designated Persons/Employees, Connected Persons of the Company and their immediate relatives are advised not to deal in the shares of the Company during this period. The date of the meeting of the Board of Directors to approve the Quarterly and Yearly Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2026 will be informed in due course.

Natraj Proteins Ltd, an Agri Business company, has reported its financial results for the quarter and nine months ended on 31st December 2025. The company's total income stood at INR 2697.49 Lakhs for the quarter and INR 334281 Lakhs for the nine months. The cost of materials consumed was INR 2094.36 Lakhs for the quarter and INR 2747.38 Lakhs for the nine months. The profit before tax was INR 11.76 Lakhs for the quarter and INR -117.65 Lakhs for the nine months. The company's earnings per equity share for the quarter was INR 71.72 and for the nine months was INR -4.41. The results were reviewed by the Audit Committee and approved by the Board at its meeting held on 13th February 2026.

The Board of Directors of Natraj Proteins Ltd. considered and approved the standalone un-audited financial results for the quarter and nine months ended 31st December, 2025. The company operates in the Agri Business segment only. The financial results are prepared in compliance with Indian Accounting Standards as notified under Section 133 of the Companies Act, 2013. The company has assessed the incremental impact of the new Labour Codes and found it to be not material. Once Central/ State Rules are notified, the company will evaluate additional impact, if any, on the measurement of employee benefits.

Natraj Proteins Ltd has announced that its Board of Directors will meet on February 13, 2026, to consider and approve the Standalone Un-Audited Financial Results for the quarter and nine months ended 31st December, 2025. The meeting will also consider the Limited Review Report by the Statutory Auditors for the same period. The trading window for dealing in the company’s securities is closed and will open 48 hours after the financial results are declared to the Stock Exchanges.

Natraj Proteins Ltd. has announced that the trading window for its shares will be closed from 1st January, 2026 till the completion of 48 hours after the declaration of unaudited financial results for the quarter and nine months ended on 31st December, 2025. This decision is in accordance with the SEBI (Prohibition of Insider Trading) Regulation, 2015 and the BSE circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019. The window for trading in the shares of the Company shall remain close from 1st January, 2026 till completion of 48 hours after the declaration of the Quarterly and Nine Months Unaudited Financial Results for the Quarter and Nine Months ended on 31st December, 2025. All the Promoter and Promoter group, Directors, KMP’s, Designated Persons/Employees, Connected Persons of the Company and their immediate relatives are advised not to deal in the shares of the Company either directly or indirectly during the aforesaid period.